Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

NCT00110955 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Non-Myeloid Malignancies

Interventions

DRUG: Darbepoetin alfa
DRUG: Placebo

Sponsor

Amgen